NCT05525468View on ClinicalTrials.gov

A Phase 1 Study of TDM-180935 Following Topical Administration in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 8, 2023

Primary Completion Date

August 18, 2023

Study Completion Date

October 13, 2023

Conditions
Healthy
Interventions
DRUG

TDM-180935

TDM-180935 topical ointment

DRUG

Placebo

Placebo for TDM-180935 topical ointment

Trial Locations (1)

07410

TKL Research, Inc., Fair Lawn

All Listed Sponsors
collaborator

Therapeutics, Inc.

INDUSTRY

lead

Technoderma Medicines Inc.

INDUSTRY